Related Experiment Video
Updated: Jun 10, 2026

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Frontotemporal dementia phenotype associated with MAPT gene duplication.
Anne Rovelet-Lecrux1, Didier Hannequin, Olivier Guillin
1Inserm U614, Faculty Medicine, University of Rouen, Rouen, France.
Journal of Alzheimer'S Disease : JAD
|July 17, 2010
Summary
A 17q21.31 microduplication including the MAPT gene was identified in patients with frontotemporal lobar degeneration (FTLD). This finding expands the known genetic causes of FTLD.
Area of Science:
- Genetics
- Neuroscience
Background:
- Microduplications at 17q21.31 have been linked to neurodevelopmental disorders.
- The MAPT gene, crucial for microtubule function, is implicated in frontotemporal lobar degeneration (FTLD).
Observation:
- This study investigated chromosomal rearrangements in FTLD patients.
- A 439-kb microduplication at 17q21.31, encompassing MAPT, IMP5, CRHR1, and STH genes, was identified in a family with FTLD and memory impairment.
Findings:
- The identified microduplication in FTLD patients expands the known genetic landscape of the disease.
- The phenotype in affected individuals aligns with tau pathology patterns observed in animal models.
Implications:
- This discovery suggests 17q21.31 microduplications are a potential cause of FTLD.
- Further research is needed to confirm the exact gene(s) responsible and the precise pathological mechanism.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Microtubule Associated Proteins (MAPs)
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
